Measles, mumps and rubella(MMR)
MMR vaccine for human medicine (measles, mumps, rubella)
HSN 3002 41 23 (Measles, mumps and rubella vaccine) is subject to Central Drugs Standard Control Organisation (CDSCO) import licensing and batch release certification under the Drugs and Cosmetics Act, 1940. A registration certificate for the drug and a certificate of analysis must accompany every consignment, with all mandatory documents uploaded in e-Sanchit before customs out-of-charge.
- Import licence for drugs from CDSCO
- Registration certificate from CDSCO
- Batch release certificate from CDSCO
- 1Obtain a valid import licence for drugs (document code 9111dc) and a registration certificate for the MMR vaccine (document code 101dc1) from CDSCO before filing the bill of entry. Both documents must be current and uploaded in e-Sanchit prior to customs out-of-charge.Drugs and Cosmetics Act, 1940 · CDSCO import licensing regime · document codes 9111dc and 101dc1
- 2Upload the certificate of analysis for the drug (document code 0010dc), the batch release certificate (document code 0030dc), and the consignment label (document code 0110dc) in e-Sanchit at the bill of entry stage. The proper officer will verify all five mandatory documents before granting out-of-charge.CDSCO mandatory document requirement · document codes 0010dc, 0030dc, 0110dc
The single most common error on this tariff line is presenting a valid import licence while omitting the batch release certificate or certificate of analysis — each is an independent mandatory document and the absence of any one of the five required uploads triggers detention pending regularisation. The batch release certificate is product-specific and lot-specific; a certificate from a prior shipment is not transferable to a new consignment, and substitution renders the bill of entry non-compliant regardless of licence validity.